Grace E. Stutzmann (Beth), Ph.D.

Associate Professor
Department of Neuroscience
Chicago Medical School
Room 2.216
Building: BSB
Phone: 847.578.8540
Fax: 847.578.8515

Stutzmann GE, Mattson MP (2011)  Endoplasmic reticulum Ca2+ handling in excitable cells in health and disease.  Pharmacological Reviews, 63 (3):700-27.

Goussakov I, Chakroborty S, Stutzmann GE (2011)  Generation of dendritic CA2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons.  Channels, 5(1):9-13.

Bruno A, Huang J, Bennett DA, Marr R, Hastings ML, Stutzmann GE (2011)  Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's Disease.  Neurobiology of Aging (epub ahead of print).

Chakroborty S, Stutzmann GE (2011)  Early Ca2+ dysregulation in Alzheimer's disease:  setting the stage for synaptic dysfunction.  Science China Life Sciences, 54(8):752-762.  (Paper submitted in association with 2011 Ca2+ Binding Proteins Meeting, Beijing, China)

Demuro A, Parker I, Stutzmann, GE (2010) Ca2+ signaling and amyoid toxicity in Alzheimer's disease.  Journal of Biological Chemistry, 285(17):12463-8.

Goussakov I, Miller M, Stutzmann GE (2010) NMDA-mediated Ca2+ influx drives ryanodine receptor activation in dendrites of young Alzheimer's disease mice.  Journal of Neuroscience 30(36):12128-37.

Chakroborty S, Goussakov I, Miller MB, Stutzmann, GE.  (2009)  Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.  Journal of Neuroscience, 29: 9458-9470.  *Faculty of 1000 Recommended Reading Award

Stutzmann GE, (2008) Seeing the brain in action: how multiphoton imaging has advanced our understanding of neuronal function.  Microscopy and Microanalysis, 14(6):482-91.  *Best Biological Paper Award

 Stutzmann GE, (2007) The pathogenesis of Alzheimer disease: Is it a lifelong ‘calciumopathy’?   
The Neuroscientist, 13(5):546-59.

Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, LaFerla F (2007) Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer mouse models.  Annals of the New York Academy of Science 1097:265-277.

Stutzmann GE, Smith I, Caccamo A, Oddo  S, LaFerla FM, Parker I. (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult and aged Alzheimer’s disease mice. Journal of Neuroscience,
26(20) 5180-5189.

Stutzmann GE, (2005) Calcium dysregulation, IP3, and Alzheimer’s disease. The Neuroscientist, 11(2):110-5.

Stutzmann GE and Parker I. (2005) Dynamic multi-photon imaging: a live view from cells to systems.  Physiology, 20:15-21.

Stutzmann GE, Caccamo A, LaFerla FM, Parker I. (2004) IP3-mediated Ca2+ signaling is exaggerated in cortical neurons from mutant presenilin-1 knock-in mice.  Journal of Neuroscience, 24(2) 508-513.

Stutzmann GE, LaFerla FM, Parker I. (2003) Ca2+ signaling in mouse cortical neurons studied by two-photon imaging and photoreleased inositol triphosphate. Journal of Neuroscience, 23(3):758-65.

Marchant J, Stutzmann GE, Leissring M, LaFerla F, Parker I. (2001) Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling. Nature Biotechnology, 19:645-649.

Stutzmann GE, Marek GJ and Aghajanian GK. (2001)  Adenosine preferentially suppresses serotonin2A-receptor enhanced EPSC’s in layer V neurons of the medial prefrontal cortex. Neuroscience.  105:55-69.

Stutzmann GE, LeDoux JE. (1999) GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. Journal of Neuroscience,

Stutzmann GE, McEwen BS, LeDoux JE. (1998)  Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. Journal of Neuroscience, 18(22):9529-38.

Li XF, Stutzmann GE, LeDoux JE. (1996) Convergent but temporally separated inputs to lateral amygdala neurons from the auditory thalamus and auditory cortex use different postsynaptic receptors: in vivo intracellular and extracellular recordings in fear conditioning pathways. Learning and Memory, 3(2-3):229-42.

Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR. (1996)  The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse, 22(1):35-45.

Life in Discovery
Neuroscience Faculty
3333 Green Bay Road, North Chicago, Il 60064-3095 • 847-578-3000